CD160 and B-cell chronic lymphocytic leukemia: Only one case expressed CD160 by percentage and by MFIR, but none of them had both CDs160/ 200 ratios or percentage expression above defined thresholds; this shows the power of using both markers co-expression in discriminating CLL and other CLPD cases with score 3.